Issue : The Pharmaceutical Journal, April 2012
Sort by: Newest first Oldest first A-Z Z-A
-
It ain’t so broke; don’t fix it (yet) Subscription
Where does self-selection end and individual choice begin? This seems to be at the heart of the debate about whether customers should be free to pick a pharmacy medicine from an open shelf or not, and what safeguards can be put in place to prevent them from buying an unsuitable or a potentially dangerous product.
-
Omega-3 of no benefit for MS patients
Omega-3 fatty acid supplements show no benefit in treating multiple sclerosis, either alone or in combination with interferon beta-1a, according to a randomised controlled trial published online in the Archives of Neurology last week (16 April 2012).
-
Over 40pc of patients not told about side effects on discharge
Well over a third of patients (43 per cent) were not told about the possible side effects of their medicines when discharged from hospital in England last year, according to the latest NHS inpatient survey.
-
Self-selection of pharmacy medicines not backed in PJ Online poll
Pharmacy medicines should not be available for self-selection by customers, according to the results of the latest PJ Online poll.
-
Pharmacists meet GPs to discuss and develop NMS
THREE quarters of local pharmaceutical committees have met their GP counterparts to discuss the new medicine service, an LPC survey has revealed.
-
More pharmacy support from Earl Howe
Firm backing for pharmacy's role in England’s reformed NHS was given yesterday (25 April 2012) by pharmacy minister Earl Howe.
-
HLPs more likely to be offered new services
Healthy living pharmacies (HLPs) are more attractive to commissioners than their non-HLP competitors, participants heard at the Clinical Pharmacy Congress in London last week (20–21 April 2012).
Show 10 per page20 per page50 per page
